Studienzentrum am Raschplatz

At Studienzentrum am Raschplatz in Hannover, the oncology research program focuses on cancers of the blood and lymphatic system as well as solid tumors, with trials designed to improve treatment effectiveness, survival outcomes, and tolerability.

• Studies in multiple myeloma, follicular lymphoma, and chronic myeloid leukemia
• Research in non-small cell lung cancer and advanced breast cancer
• Evaluation of new combinations aimed at better disease control and longer progression-free survival

The site contributes to testing innovative cancer therapies and comparing them with current standard treatments to support more effective and better-tolerated care.

This research area centers on hematologic disorders such as myelodysplastic syndrome, polycythemia vera, and warm autoimmune haemolytic anaemia, with a strong emphasis on improving blood counts, reducing symptoms, and lowering transfusion needs.

• Trials for anemia management in lower-risk myelodysplastic syndromes
• Studies assessing response in polycythemia vera and treatment resistance
• Research on restoring hemoglobin levels in autoimmune hemolytic anaemia

These studies aim to refine treatment choices for patients with chronic blood disorders and to identify who may benefit most from newer therapies.

The site also includes trials in immune-mediated blood diseases, especially conditions where the immune system affects red blood cells or treatment response. The focus is on testing therapies that can improve disease control while maintaining acceptable safety and tolerability.

• warm autoimmune haemolytic anaemia studies evaluating durable hemoglobin response
• Research into treatment effectiveness for patients who have already received prior therapy
• Clinical interest in balancing immune control with everyday quality of life

By studying these conditions, Onkologisches Studienzentrum helps advance care for patients with difficult-to-treat immune-related disorders.

Although this area is less prominent than oncology and hematology, the site’s broader research profile includes disease patterns where inherited or biologic factors influence treatment response and long-term outcomes.

• Work that may inform how patients with genetically influenced disease features are identified and managed
• Research approaches that support more personalized treatment selection
• Clinical evaluation aimed at better understanding variable responses across patient groups

Overall, the research environment is centered on practical improvements in diagnosis, treatment selection, and patient benefit across complex disease settings.